QuietDose wins BSIF Product Innovation Award
Measures noise levels in the workplace
The award, which recognises new and innovative products that contribute to improvements in occupational safety and health, was presented at the RoSPA Occupational Health and Safety Awards Gala Dinner held during Safety and Health Expo 2011.
QuietDose measures the actual noise levels reaching a worker’s eardrums over a shift. When worn as hearing protection, the device measures sound pressure levels inside the protector. During periods when it is not worn, such as rest periods, QuietDose continues to measure the ambient noise levels, recording the worker's noise exposure throughout the working day.
According to Honeywell Safety Products, the supplier of the Howard Leight brand in the UK, QuietDose provides safety managers with an unprecedented level of personalised data on a worker’s exposure to noise at work. This results in fewer documented cases of occupational hearing loss for employees, and fewer claims and lower compensation costs for employers. Supervisors can also use the personalised data to improve productivity by better managing worker deployment in areas of extreme noise.
QuietDose also enables workers to monitor and control their own noise exposure in real-time. Flashing alerts indicate when noise exposure reaches or exceeds prescribed limits.
“We are committed to providing a more holistic approach to occupational hearing loss prevention,” said Ian Shepherd, hearing national product sales manager for Honeywell Safety Products in the UK.
“We are honoured to be recognised by the British Safety Industry for QuietDose and the pursuit of a more deterministic and preventive approach towards hearing conservation in the workplace.”
You may also like
Hi Tech Manufacturing
Anxine responds to rising demand for integrated turnkey packaging solutions
Anxine has observed that more customers are moving away from purchasing individual machines and are instead choosing complete one-stop turnkey solutions that are easier to plan, manage, and put into operation
Containment
FDA warning letter flags serious violations at New Jersey manufacturing facility for GLP-1 weight loss jabs
The US Food and Drug Administration has issued a warning letter of deficient cleanroom design, contamination controls and quality oversight in sterile GLP-1 drug production at a New Life Pharma facility